With the Oncology Brothers, Uma Borate, MD, discusses how ziftomenib is showing promising results as a targeted therapy for NPM1-mutated and KMT2A-rearranged acute myeloid leukemia (AML) in the ...

The original TV show lasted just one season; kids moved on to the next shiny thing. My brother and I lost interest because we never had a plastic stadium, limiting our Beyblade duels to hard ...